AP
TMO icon

Arlington Partners’s Thermo Fisher Scientific TMO Stock Holding History

Arlington Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$310K Buy
618
+114
+23% +$54.7K 0.56% 7
2026
Q1 		$248K Buy
+504
New +$274K 0.49% 9
2025
Q4 		– Sell
-10,939
Closed -$5.31M – 52
2025
Q3 		$5.31M Buy
10,939
+176
+2% +$81.9K 1.83% 11
2025
Q2 		$4.36M Buy
10,763
+2,744
+34% +$1.15M 1.61% 39
2025
Q1 		$3.99M Buy
8,019
+1,061
+15% +$575K 1.57% 36
2024
Q4 		$3.62M Buy
6,958
+307
+5% +$169K 1.41% 44
2024
Q3 		$4.11M Buy
6,651
+1,053
+19% +$623K 1.61% 39
2024
Q2 		$3.1M Buy
5,598
+111
+2% +$63.6K 1.54% 49
2024
Q1 		$3.19M Sell
5,487
-159
-3% -$89.2K 1.62% 29
2023
Q4 		$3M Buy
5,646
+62
+1% +$30K 0.86% 40
2023
Q3 		$2.83M Buy
5,584
+5,374
+2,559% +$2.86M 1.16% 28
2023
Q2 		$110K Sell
210
-25
-11% -$13.5K 0.02% 231
2023
Q1 		$135K Buy
235
+64
+37% +$36.1K 0.02% 164
2022
Q4 		$94.2K Hold
171
– – 0.01% 157
2022
Q3 		$87K Hold
171
– – 0.03% 149
2022
Q2 		$93K Hold
171
– – 0.03% 170
2022
Q1 		$101K Hold
171
– – 0.03% 178
2021
Q4 		$114K Buy
171
+125
+272% +$78K 0.03% 185
2021
Q3 		$26K Hold
46
– – 0.01% 320
2021
Q2 		$23K Hold
46
– – 0.01% 242
2021
Q1 		$21K Hold
46
– – 0.01% 301
2020
Q4 		$21K Buy
+46
New +$21.6K 0.01% 147

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Arlington Partners's TMO Position: Q2 2026 in Review

Arlington Partners increased its Thermo Fisher Scientific (TMO) stake by 23% in Q2 2026, buying an estimated $54.7K and bringing the position to 618 shares worth $310K. The position accounts for 0.56% of the portfolio, ranked #7.

Arlington Partners first reported a position in TMO in Q4 2020 and has held it in 22 quarters since. The position peaked at $5.31M in Q3 2025. 429 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Arlington Partners held 618 shares of Thermo Fisher Scientific worth $310K as of Q2 2026.
  • Arlington Partners bought 114 Thermo Fisher Scientific shares in Q2 2026, an estimated $54.7K.
  • Thermo Fisher Scientific made up 0.56% of Arlington Partners's portfolio in Q2 2026, its #7 holding.
  • Arlington Partners first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 22 quarters since.
  • Arlington Partners's Thermo Fisher Scientific position peaked at $5.31M in Q3 2025.
  • 429 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.